FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

ODNI sends criminal referrals to DOJ for ex-IG, whistleblower tied to Trump impeachment

Catholic JFK Laid Out How Presidents Should Deal With Papal Criticism in Famous 1960 Speech

School Agrees to Pay Up After Counselor Was Fired for Objecting to Transgender Policy

Woman added to FBI’s Ten Most Wanted list arrested hours later after tips poured in from Florida: Patel

Hunter Biden now living abroad as legal troubles mount, court filing reveals

DC curfew ends as teen takeover fears clock in – city braces for chaos amid spring break mayhem

Watch: As Walls Close in, Schiff’s Own Words Come Back to Haunt Him in Resurfaced Pardon Video He Wishes Didn’t Exist

What to know about the Freedom 250 UFC fight on the White House lawn

Left-Wing Mob, Violent Threats Force Erika Kirk to Miss TPUSA Event with JD Vance

Trump reveals he has multi-pick SCOTUS plan ready as retirement speculation heats up

WATCH: Ex-NATO chief draws red line as Trump fumes alliance abandoned US during Iran war

Jeanine Pirro accused of trying to ‘circumvent’ Jerome Powell investigation through unprompted Fed ‘tour’

Millions tap Trump tax cuts this filing season as refunds top $3,400

Trump-Tillis tiff deepens as president says he ‘quit,’ concedes Fed fight could doom new chair confirmation

Man with Joker-inspired rifle fires gun, runs into traffic near Trump golf course, deputies say

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”